BCI is a Singapore-based biotechnology company specializing in the development and manufacturing of Next-Generation Monolithic Media for pharmaceutical purification. With a focus on performance, scalability, and material innovation, BCI is enabling the next wave of Cell and Gene Therapy manufacturing through advanced flow architecture and industry-leading purification efficiency.
Company Details
- Employees
- 5
- Founded
- 2024
- Address
- Singapore , Sg
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Keywords
- chromatography, virus purification, monolith, Bacteriophages, AAV, LV, mRNA, pDNA, exosomes.
- HQ
- Singapore
Biochromatographix International Questions
Biochromatographix International's website is http://www.biochromatographix.com
Biochromatographix International's LinkedIn profile is https://sg.linkedin.com/company/biochromatographix
Biochromatographix International has
5 employees.
View email and phone details for 5
employees at Biochromatographix International.
Biochromatographix International's industry is
Biotechnology Research
Biochromatographix International's top competitors are
Enhanzcom Pte Ltd,
Lotte Biologics,
Vetter Pharma,
Cargo-Tech Consultancy,
Sginnovate,
Cellvec Pte Ltd,
Akeso Biopharma,
Sierra Biosystems Inc.,
All About Packaging,
Abasia Biolabs.
Biochromatographix International's categories are Biotechnology Research
Biochromatographix International's founding year is 2024
